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BACKGROUND Studies aimed at validating canine visceral leishmaniasis diagnostic tests present heterogeneous results regarding 
test accuracy, partly due to divergences in reference standards used and different infection evolution periods in animals.
OBJECTIVE This study aimed to evaluate the accuracy of the rapid test-dual path platform (TR-DPP) (Biomanguinhos®), EIE-
Leishmaniose-Visceral-Canina-Biomanguinhos (EIE-LVC) (Biomanguinhos®), enzyme-linked immunosorbent assay (ELISA) 
rK39 (in-house), and the direct agglutination test (DAT-Canis) against a reference standard comprising parasitological and 
molecular techniques.
METHODS A phase II/III validation study was carried out in sample sera from 123 predominantly asymptomatic dogs living in 
an area endemic for visceral leishmaniasis.
FINDINGS Sixty-nine (56.1%) animals were considered infected according to the reference standard. For each test, the sensitivity 
and specificity, respectively, were as follows: TR-DPP, 21.74% [confidence interval (CI)95% 13.64% to 32.82%] and 92.59% 
(CI95% 82.45% to 97.08%); EIE-LVC, 11.59% (CI95% 5.9% to 21.25%) and 90.74% (CI95% 80.09% to 95.98%); ELISA rK39, 
37.68% (CI95% 27.18% to 49.48%) and 83.33% (CI95% 71.26% to 90.98%); and DAT-Canis, 18.84% (CI95% 11.35% to 29.61%) 
and 96.30% (CI95% 87.46% to 98.98%).
CONCLUSION We concluded that improving the sensitivity of serum testing for diagnosing asymptomatic dogs must constitute 
a priority in the process of developing new diagnostic tests to be used in the visceral leishmaniasis control program in Brazil.
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In the American continent, the control of metazoo-
notic canine visceral leishmaniasis (CVL) is crucial for 
reducing the occurrence of human visceral leishmani-
asis (HVL); the dog is the main reservoir for Leishmania 
(Leishmania) infantum, the etiological agent of CVL in 
urban areas.(1,2)
The Brazilian Leishmaniasis Control Program pre-
scribes detection and euthanasia for infected dogs, 
among other measures. The program sequentially uses 
two serological tests, which present a lower diagnostic 
accuracy in asymptomatic dogs or in those in the initial 
stages of the infection.(3,4,5,6,7,8) Although some works in-
dicate that serological tests may be used with efficacy for 
diagnosing asymptomatic animals,(6,9) the performance 
of serological tests may be up to 20% inferior to the per-
formance of molecular tests in that subgroup.(7,8,9,10)
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Molecular diagnostic tests are not routinely used in 
public health programs because of the relative difficul-
ties regarding the need for complex laboratorial infra-
structure, the elevated costs, and the lack of commer-
cially available assays, as well as other limitations.(7,8,9,10)
The diagnosis for animals with symptomatic CVL 
has fewer problems because those animals often pres-
ent levels of antibodies that are specifically detectable 
through serological tests that are commercially avail-
able.(11,12,13) Symptomatic animals also present a higher 
parasite load, allowing its detection in peripheral blood 
and tissues through molecular diagnosis methods.(14)
The role of infected dogs that remain asymptom-
atic in the transmission cycle of visceral leishmaniasis 
among dogs and from dogs to humans has not been 
widely clarified. Theoretically, a smaller parasite load in 
asymptomatic dogs would translate to a lower infectious 
capacity in sand flies. However, asymptomatic animals 
constitute most of the infected population, which means 
that they could be effectively relevant in transmitting the 
parasite to its vectors.(15,16,17,18)
Considering that most infected dogs remain asymp-
tomatic for long periods, it is important that infected ani-
mals are accurately detected, regardless of the control 
measure to be applied to that canine population. In fact, 
mathematical modelling indicates that the key to the po-
tential success of CVL control may be the identification 
of asymptomatic dogs.(19,20)
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In that sense, new diagnostic tests are under de-
velopment with promising results in their initial stag-
es,(21,22,23,24) but however, it is necessary to challenge 
these against a robust reference standard. The current 
context is characterised by a lack of consensus about the 
best reference standard for the validation of diagnostic 
tests for CVL, and few studies have used reasonably ad-
equate reference standards.(5,25)
Among the tests under development, the DAT-Canis 
is based on the direct agglutination principle, which uses 
Leishmania infantum raw antigen. The test was devel-
oped by René-Rachou Institute (Fiocruz, Minas Gerais), 
and its prototype consists of a kit that allows up to 480 
reactions at low costs (US$0.44/reaction, considering in-
house testing), with a simple methodology of execution, 
and no need for complex laboratorial infrastructure.
The present research aimed to study the accuracy 
of certain tests against a reference standard constitut-
ed of a combination of parasitological and molecular 
techniques. The tests evaluated were as follows: rapid 
test-dual path platform (TR-DPP) (Biomanguinhos®); 
EIE-Leishmaniose-Visceral-Canina-Biomanguinhos 
(EIE-LVC) (Biomanguinhos®), which is currently rec-
ommended for CVL diagnosis in Brazil; the immunoen-
zymatic test using recombinant antigen rK39 (in-house); 
and the direct agglutination test (DAT-Canis) for serum 
samples from dogs resident in an endemic area of the 
Federal District of Brazil.
MATERIALS AND METHODS
Type of study - This was a phase II/III validation 
study(26) in serum samples collected consecutively in a 
random, non-preselected sample of dogs that reside in an 
endemic area for visceral leishmaniasis.
Samples - The samples used in this study are part 
of a biobank kept at the Laboratory for Leishmaniasis 
at the Centre for Tropical Medicine (NMT/FM/UnB) 
obtained during the study “Risk, diagnosis and progno-
sis of canine visceral leishmaniasis in the Federal Dis-
trict”. Samples were collected from dogs residing in an 
endemic area of the Federal District. They participated 
in the baseline assessment for a cohort study aiming to 
determine the role of socioeconomic factors and owner 
care on the risk of CVL acquisition. The dogs included 
in this study were randomly selected, and sample col-
lection was done in the period between October 2015 
and May 2017.
The criteria for sample inclusion in the present vali-
dation study were to have sufficient biological material 
available for carrying out serological testing, and to have 
taken all tests that composed the reference standard.
Clinical assessment - The dogs were clinically eval-
uated without previous knowledge of their infection sta-
tus, and a signal score was attributed to each one accord-
ing to a model adapted from that used by Proverbio et 
al.,(12) which consisted of clinical aspects listed as items 
in a table with intensity degrees (Table I). The model 
used by us excluded the items that could not be deter-
mined through a single physical exam. The excluded 
items were appetite alterations, mental state alterations, 
intolerance to exercise, weight loss, polyuria, polydipsia, 
and proteinuria. These items, at their highest intensities, 
could have added up to 20 points to the score.
Since there was more than one veterinarian prac-
titioner collecting samples and physical exams, other 
items, the assessment of which might have been subjec-
tive, were altered, such that only the presence or absence 
of these signals would be detected. These items were 
skin lesions, hepatosplenomegaly, epistaxis, vomiting, 
diarrhoea, claudication, altered pigmentation, hyperker-
atosis, and onychogryphosis. This caused the exclusion 
of these items, which, at their highest intensities, could 
have added up to 21 points to the score.
Upon applying these adaptations to a pilot project 
with 20 assessments and two veterinarians, the modified 
clinical score could reach a maximum of 46 points in-
stead of the 87 points obtained in the initial model.
Composite reference standard - The reference stand-
ard was composed by the following tests: amastigotes 
visualisation in the bone marrow smear; promastigotes 
isolation in bone marrow culture; parasite DNA detected 
by conventional polymerase chain reaction (PCR) tar-
geting the conserved region of kDNA (and confirmed by 
PCR targeting the ITS1 gene) in peripheral blood and the 
bone marrow; and parasite DNA detected through the 
real time PCR technique (qPCR) targeting kDNA in the 
blood and the bone marrow.
All animals were submitted to all the tests compos-
ing the reference standard.
Case definition - The animal was considered infect-
ed when there was a positive result to any of the exams in 
the reference standard. The animal was considered not 
infected when there was a negative result in every test 
included in the reference standard.
Execution of reference standard tests - The profes-
sionals who executed the reference standard tests did not 
have knowledge of the characteristics of the animal that 
was the source of the samples.
Bone marrow smears were stained with Giem-
sa (Merck®) or Panótico (Instant Prov, Laboratory 
NewProv) for direct examination of the slides and ob-
served in an optical microscope with an objective of 
100x and immersion oil to identify amastigote forms.(27) 
For each dog, at least two slides were examined.
A drop of aspirated bone marrow was inoculated 
into culture medium that was prepared according to the 
methodology adopted in the Leishmaniasis Laboratory 
in the Centre for Tropical Medicine of the University of 
Brasilia. Each sample was inoculated in duplicate, and 
the tubes were assessed every two days in an inverted 
optical microscope to seek typical movement that would 
indicate the presence of Leishmania spp. promastigotes 
during the 30-day period.(28)
Molecular tests - The conventional PCR method tar-
geting kDNA(29) was chosen for triaging the sample, and 
the ITS1 assay(30) was used to confirm the presence of 
Leishmania spp. All precautions to avoid contamination 
were applied, including performing the pre-PCR, PCR, 
and post-PCR procedures in separate environments.
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DNA extraction - After transport in refrigerated ther-
mal boxes, the samples of blood mixed with EDTA were 
kept at -20ºC until processing. DNA was extracted using 
the Wizard Genomic DNA purification kit (Promega, 
Madison, WI, USA) according to the manufacturer’s 
instructions for a 300 µL sample. Lastly, the extracted 
DNA was hydrated overnight using 100 µL of hydration 
solution. For each extraction procedure, an ultra-pure 
water negative control was included.
kDNA-conserved region PCR - The reaction was 
carried out using one forward: 5’GGG GAG GGG CGT 
TCT GCG AA 3’ and two backward: BW-CA: 5’CCG 
CCC CTA TTT TAC ACC AAC CCC 3’ and BW-B: 
5’GGC CCA CTA TAT TAC ACC AAC CCC 3’ target-
ing 120 bp of the kDNA-conserved region.(29) Genom-
ic DNA samples extracted from Leishmania infantum 
(MCER/BR/79/M6445), L. (L.) amazonensis (MHOM/
BR/75/M2904), and L. (Viannia) braziliensis (IFLA/
BR/67/PH8) were used as positive controls, and the same 
negative control was used as in the extraction step.
A 10 µL reaction was done with 1 µL of DNA sam-
ple, 0.3 µL of Taq (5 U), 1 µL of dNTPs (0.5 mM), 0.5 
µL initiators BW-B and BW-CA (in the concentration of 
10 µM) and 1.0 µL FW (10 µM), 1 µL of MgCl2 (50 mM) 
and 1 µL of 5X buffer. The reaction was carried out in a 
Techne FTC-PLUS thermocycler (Bibby Scientific LTD, 
United Kingdom) with the following settings: initial de-
naturalisation of 95ºC for 5 min, 35 cycles (heating at 
95ºC for 30 s, annealing at 64ºC for 30 s and extension 
at 72ºC for 30 s), and final extension at 72ºC for 5 min.
ITS1 gene PCR - The ITS reaction was carried out 
using ITS-219F primers (5’ AGC TGG ATC ATT TTC 
CGA TG 3’) and ITS-219R (5’ ATC GCG ACA CGT 
TAT GTG AG 3’); the size of the amplicon was 265 bp.(30) 
For that group of PCR reactions, the positive control was 
DNA extracted from a L. infantum promastigote cul-
ture (MCER/BR/79/M6445). For the negative control, 
MilliQ water was used. The reaction was done in a total 
volume of 25 µL, with 3 µL DNA, 0.5 µL of each primer 
(10 µM), 0.2 µL of dNTPs (0.5 mM), 5.0 µL of buffer 
5X, 0.3 µL of Taq (5U), and 0.75 µL of MgCl2 (50 mM). 
The reaction was performed in a thermocycler (Techne 
FTC-PLUS Bibby Scientific LTD, United Kingdom) us-
ing the following cycling conditions: initial denaturation 
at 95ºC for 5 min; 40 cycles of heating at 95ºC for 30 s, 
annealing at 57ºC for 30 s, and extension at 72ºC for 30 
s; and final extension at 72ºC for 5 min. The PCR prod-
ucts were maintained at 4ºC until viewed in a 7.5% pol-
yacrylamide gel (150 volts, 75 Amp for 90 min) followed 
by silver staining.
TABLE I
Modified clinical score for canine visceral leishmaniasis (CVL) according to the adaptation from the model by Proverbio et al.(12)
Findings
Score
0 1 2 3
Bodily condition Obese/Normal Thin Cachectic --
Mucosae Normal Pale Jaundiced --
Dehydration Absent Light Moderate to intense --
Muscle atrophy on limbs Absent Light Moderate to intense/widespread --
Skin lesions Absent Present -- --
Hepatosplenomegaly Absent Present -- --
Conjunctivitis and / or Keratitis Absent Unilateral and light Severe unilateral / bilateral --
Uveitis and / or Blepharitis Absent Unilateral and light Severe unilateral / bilateral --
Lymph adenomegaly Absent 1 to 2 lymph nodes -- 3 or more / widespread
Epistaxis Absent Present -- --
Mouth ulcers or nodules Absent 1 to 2 3 or more --
Vomit Absent Present -- Frequent, with vomit
Diarrhea Absent Present -- --
Claudication Absent Present -- --
Erythema Absent 1 to 25% of the body 25 to 40% of the body 40% or more of the body
Dry exfoliative dermatitis Absent 1 to 25% of the body 25 to 40% of the body 40% or more of the body
Ulcerative dermatitis Absent 1 to 25% of the body 25 to 40% of the body 40% or more of the body
Nodular dermatitis Absent 1 to 25% of the body 25 to 40% of the body 40% or more of the body
Pustular dermatitis Absent 1 to 25% of the body 25 to 40% of the body 40% or more of the body
Alopecia Absent 1 to 25% of the body 25 to 40% of the body 40% or more of the body
Altered pigmentation Absent Present -- --
Hyperkeratosis of truffles  
and cushions Absent Present -- --
Onychogryphosis Absent Present -- --
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Real-time PCR (qPCR) - The reaction was set off 
with the primers 5’ GGC CCA CTA TATTAC ACC 
AAC CCC 3’ and 5’ GGG GTA GGG GCG TTC TGC 
GAA 3’, as described by Pita-Pereira et al.(31) Each re-
action was carried out using 0.2 µM of each initiator, 2 
µL of DNA samples (25 ng/µL), and 1X Power SYBR 
Green PCR Master Mix(2 µL), with the final volume 
per reaction being 20 µL. All reactions were conduct-
ed using two positive controls containing 5 ng/µL and 
0.005 ng/µL of DNA extracted from the L. infantum pro-
mastigotes (MCER/BR/79/M6445). Two negative con-
trols were also set: a blank without DNA and another 
control with DNA from HEK cell culture. The results 
were considered positive up to Ct 35, and showed a sen-
sitivity of 0.005 ng/mL for L. infantum DNA. The results 
were classified as positive or negative. The thermocy-
cler QuantStudio 3 (Applied Biosystems) was used to 
perform qPCR, with the following cycling conditions: 
initial denaturation at 94ºC for 12 min and 40 cycles of 
denaturation at 94ºC for 30 s, annealing at 55ºC for 30 s, 
and extension at 72ºC for 8 s.
Serological tests - The TR-DPP® Leishmaniose Vis-
ceral Canina (Biomanguinhos, Rio de Janeiro, RJ, BR) 
and ELISA (EIE-Leishmaniose Visceral Canine) (Bio-
manguinhos®) tests were carried out in serum samples 
sent to the Environment Surveillance Laboratory of the 
Federal District (DIVAL), the government branch that is 
responsible for controlling zoonoses in the Federal Dis-
trict. The tests were executed according to manufactur-
er’s recommendations and to parameters established by 
the Ministry of Health.(32)
The ELISA rK39 was carried out in the René-Ra-
chou, Fiocruz, Research Institute in Belo Horizonte. The 
Nunc MaxiSorp plates were sensitised with a rK39 anti-
gen at a concentration of 1 µg/mL diluted in carbonate/
bicarbonate (pH 9.6) in a wet chamber inside a refriger-
ator (2 to 8ºC) overnight. Afterwards, they were frozen 
at -20ºC until use. The plates were washed three times 
with a phosphate buffer containing Tween 0.05% (TF-
Tween). Additionally, 200 µL/well of diluted 5% milk 
(TF-Tween-milk 5%) was added to each plate well and 
incubated for 2 h in a wet chamber at 37ºC. After new 
lavages, the plates were incubated in a wet chamber at 
37ºC with 50 µL/well of anti-IgG canine conjugate with 
peroxidase (Sigma-Aldrich, St. Louis, MO, USA) dilut-
ed 1:50.000 in 1% TF-Tween-Milk.
The plates were washed again and incubated for 5 
min in the dark with TMB (tetramethylbenzidine, Sig-
ma-Aldrich) at 50 µL/well, and the reaction was blocked 
with 50 µL/well of a solution of 1 N sulfuric acid. The 
reading was carried out using the FlexStation 3 Multi-
Mode Microplate Reader (Molecular Device, San Jose, 
CA, USA) with a wavelength of 450/620 nm. The cut-off 
was defined by the average of absorbance readings in 
13 negative control samples increased by two standard 
deviations. The samples that presented a difference in 
absorbance readings over 20% were retested.
DAT-Canis - The test kit used for serum agglutina-
tion, DAT-Canis, is composed of 10 lyophilised antigen 
vials containing stained promastigotes of L. infantum 
(MHOM/BR/2002/LPC-RPV), a rehydration solution 
vial, and a sample diluent vial.
First, the lyophilised antigen was rehydrated with 5 
mL of rehydration solution. A total of 99 µL of sample 
diluent was deposited in the well in the first V-bottom 
plate column (Greiner BioOne Produtos Médicos Hospi-
talares, Americana, SP, BR) and 50 µL in the remaining 
ones (2nd to 4th). Next, 1 µL of the serum samples was 
Fig. 1: sample selection flowchart.
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diluted in the well from the first column, making a dilu-
tion of 1:100. Then the samples were diluted to 1:800. 
The plates were incubated for an hour at room tempera-
ture and 50 µL of the previously rehydrated antigen was 
added. The plates were agitated for 5 min and incubated 
for 18 h in a dark chamber. Positive and negative control 
sera were tested in parallel with each plate. The results 
were visually read with the naked eye. The cut-off adopt-
ed for defining positive and negative results was 1:400, 
as previously described.(21) The positive samples from 
the qualitative test were retested in the same manner and 
diluted until they reached the proportion of 1:102,400.
Statistical analysis - The test results and informa-
tion on the dogs that were the sources of the samples 
were tabulated in Microsoft Excel. The Statistical Pack-
age for the Social Sciences (SPSS, IBM, Armond, New 
York, United States) was used to calculate the accuracy 
parameters and their respective 95% confidence inter-
vals. The accuracy was calculated with the sequential 
use of diagnostic testing in different combinations. The 
positive and negative predictive values were calculated 
along with the positive and negative likelihood ratios. 
A sensitivity analysis was done regarding the positive 
and negative predictive values for a hypothetical spec-
trum of infection prevalence values. Also, a comparison 
of the clinical score between infected and non-infected 
animals was performed with the Mann-Whitney U test.
Ethics - The collection of biological samples for the 
study was approved by the Ethics Committee on Animal 
Use (CEUA, from the acronym in Brazilian Portuguese) 
at the Institute of Biological Sciences at the University of 
Brasília, under UnBDoc number 11253/2015.
Legally competent owners voluntarily consented to 
the participation of their animals in the study, and they 
signed consent forms.
RESULTS
Sixty-nine out of the 123 animals (56.09%) were 
considered infected according to the composite refer-
ence standard. From the animals that presented positive 
results in the reference standard, 36.23% (25/69) were 
positive during the screening with kDNA PCR and con-
firmed through ITS1 PCR; 17.39% (12/69) had positive 
culture and direct parasitological test; and 81.15% (56/69) 
were positive in the kDNA qPCR. The raw agreement 
among the tests that composed the reference standard is 
described in Supplementary data (Table I). Fig. 1 intro-
duces the sample selection process.
Characteristics of dogs - All 123 dogs were housed 
in the Federal District, with 77 (62.6%) in the admin-
istrative area of Fercal, 39 (31.7%) from Sobradinho II, 
four (3.25%) from Lago Sul, and three (2.44%) from Pla-
no Piloto. The referred average age of the dogs was 3.21 
years (DP = 2.91 years). Sixty-two (50.41%) were male, 
59 (47.97%) were female, and two animal registers did 
not include that information.
Most of the animals presented few or no CVL symp-
toms. The average score for clinical signs suggestive of 
CVL was 2.13 points (DP = 3.44 points; median = 1.0 
point; quartiles 25 and 75 of 0 and 3 points, respective-
ly). The dogs that were not infected and were completely 
asymptomatic (zero score) were 22/55 (40%), and the 
infected and asymptomatic dogs were 24/66 (36.36%). 
Out of the 55 non-infected dogs, 46 (83.64%) presented 
a score equal to or lower than 3, whereas 55 out of the 
66 infected dogs (83.33%) presented a score equal to or 
lower than 3, as shown in Fig. 2.
Accuracy of serological tests - The positivity ob-
served in serological tests was 15.4% (19/123) in TR-
DPP, 10.6% (13/123) in EIE-LVC, 28.5% (35/123) in 
ELISA rK39, and 12.2% (15/123) in DAT-Canis. The raw 
agreement among the serological tests is demonstrated 
in Supplementary data (Table II).
Table II presents the frequency of results in serologi-
cal tests in relation to the reference standard and its ac-
curacy values.
Several sequential combinations among the serologi-
cal tests were evaluated. The specificity nearly always 
reached 100%.
The protocol recommended by the Ministry of 
Health, which used TR-DPP as screening test, would 
detect 19 samples as positive, and the EIE-LVC would 
confirm seven out of these 19 samples as positive. The 
combined sensitivity (7/69) would be 10.14% (CI95% 5.0 
to 19.49), and the combined specificity (54/54) would be 
100% (CI95% 93.36 to 100).
The combination of TR-DPP as screening tests fol-
lowed by DAT-Canis as a confirmatory test would re-
peat the results from the Ministry protocol. However, 
if ELISA rK39 were the confirmatory test, out of the 
19 positive samples from the screening, nine would be 
confirmed as positive. Thus, the sensitivity and speci-
ficity of that last combination would be 9/69 or 13.04% 
(CI95% 7.02 to 22.97) and 54/54 or 100% (CI95% 93.36 
to 100), respectively.
Fig. 2: distribution of clinical score for canine visceral leishmani-
asis (CVL) in groups of infected and non-infected animals. Fifty-five 
non-infected dogs, median 1 (IQR:0-3; interval 0-12 points). Sixty-
six infected dogs, median 1 (IQR:0-3; interval 0-26 points). (Mann-
Whitney U test; p = 0.708).
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With DAT-Canis as a screening test, out of the 15 
positive samples, seven would be confirmed by TR-DPP 
with a combined sensitivity of 7/69 or 10.14% (CI95% 
5.0 to 19.49) and the combined specificity of 54/54 or 
100% (CI95% 93.36 to 100).
Using DAT-Canis for screening and ELISA rK39 
for confirmation, out of the 15 CVL positive samples, 
nine would be confirmed as being infected; their com-
bined sensitivity would be 9/69 or 13.04% (CI95% 7.02 
to 22.97), and their combined specificity would be 53/54 
or 98.15% (CI95% 93.36 to 100). Supplementary data 
(Table III) provides further information on the accuracy 
figures for combined serological tests.
In the 56% prevalence of infection scenario observed 
in the actual sample of dogs, the positive predictive value 
(PPV) and negative predictive value (NPV) for the tests 
were as follows: DAT-Canis, 0.88 and 0.49; TR-DPP, 0.79 
and 0.49; ELISA rK39, 0.74 and 0.53; and EIE-LVC, 0.60 
and 0.55. The sensitivity analysis for PPV and NPV for 
a hypothetical scenario of infection prevalence between 
0 and 70% demonstrated similar behaviour between the 
tests, as shown in Supplementary data (Figure).
DISCUSSION
The diagnostic protocol using TR-DPP as the screen-
ing test and EIE-LVC as the confirmatory test for CVL 
has been implemented in Brazil since 2012.(33) Studies 
conducted later have evaluated the sensitivity and speci-
ficity of these tests.(4,5,8,34,35,36,37) However, the lack of a 
homogenous reference standard has caused the results of 
these studies to diverge, as each one has used a different 
criterion for defining infected cases.
With a reference standard in which dogs were con-
sidered negative when they had negative results in other 
serological tests for CVL and positive by the direct para-
sitological test in bone marrow smear, TR-DPP had a sen-
sitivity of 98% in symptomatic dogs.(35) In another study 
with asymptomatic and symptomatic dogs that used the 
immunohistochemical examination of skin biopsies as a 
reference, the accuracy for TR-DPP reached sensitivity 
levels of 82.1% (CI95% 73.7 to 88.4) and a specificity of 
98.9% (CI95% 94.4 to 99.8).(34) Another study that used 
as a reference standard a combination of parasitologi-
cal tests, including parasite cultures, conventional H&E 
histopathology, and immunohistochemical examina-
tion to assess TR-DPP showed a sensitivity of 88.0% 
(CI95% 67.5 to 96.8) and specificity of 69.2% (CI95% 
63.7 to 74.3).(4) A larger study, using the same reference 
standard, made subgroup analysis based on the presence 
of symptoms revealing that TR-DPP for asymptomatic 
dogs had a sensitivity of 75% (CI95% 42.8 to 94.5) and 
specificity of 72.9% (CI95% 68.5 to 77.1) compared to 
sensitivity of 93.8% (CI95% 82.8 to 98.7) and specificity 
of 56.4% (CI95% 46.2% to 66.3%) in symptomatic dogs.
(8) Finally, DAT-Canis showed a sensitivity of 97% in 
symptomatic dogs,(21) and its performance had not been 
previously assessed in diagnosing asymptomatic dogs.
Peixoto et al.(5) performed a meta-analysis of test accu-
racy for CVL diagnosis, and they estimated a sensitivity 
of 83.5% (CI95% 78.3 to 87.9) and a specificity of 72.9% 
(CI95% 70.5 to 75.2) for TR-DPP and a sensitivity of 89% 
(CI95% 86.9 a 90.9) and specificity of 87% (CI95% 85.6 
to 88.3) for the ELISA immunoenzymatic test with raw 
antigens. In that review, the heterogeneity was identified 
in the type of reference standard used in the studies that 
were included in the meta-analysis. The scarcity of studies 
with an asymptomatic dog population was also evident.(5)
A study that used only the parasitological diagnosis 
as a reference estimated a sensitivity of 46.2% for TR-
DPP and of 46.3% for EIE-LVC.(37) Another more recent 
study used the direct parasitological test associated with 
the parasite culture, and it estimated sensitivity for TR-
DPP of 100%; its specificity varied between 22 and 96%.
(38) The study by Silva et al.(39) used serological tests as 
a reference standard and the TR-DPP’s sensitivity was 
58.33% (CI95% 43 to 72). Carvalho et al.(10) demon-
strated that by using qPCR in blood serum samples, the 
protocol for CVL diagnosis prescribed by the Ministry 
of Health had a sensitivity of 67.24% (CI95% 54.42 to 
77.92) and specificity of 86.59% (CI95% 77.55 to 92.34).
TABLE II
Accuracy of serological tests for canine visceral leishmaniasis (CVL), Brasília, DF, 2017
Index tests
Reference standard Test accuracy (%) Likelihood ratio









DAT-Canisa (+) 13 2 18.84 96.30 5.08 0.84(-) 56 52 (11.35 to 29.61) (87.46 to 98.98) (1.19 to 21.58) (0.74 to 0.95)
EIE -LVCb (+) 8 5 11.59 90.74 1.25 0.97(-) 61 49 (5.99 to 21.25) (80.09 to 95.98) (0.43 to 3.61) (0.86 to 1.09)
R-DPPc (+) 15 4 21.74 92.59 2.93 0.84(-) 54 50 (13.64 to 32.82) (82.45 to 97.08) (1.03 to 8.33) (0.73 to 0.97)
ELISA rK39d (+) 26 9 37.68 83.33 2.26 0.74(-) 43 45 (27.18 to 49.48) (71.26 to 90.98) (1.15 to 4.41) (0.60 to 0.93)
a: direct agluttination test; b: immuno-enzymatic assay for CVL; c: rapid test dual path platform; d: enzyme linked immunosorbent 
assay rk39.w
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Nevertheless, it is valid to highlight that because of 
its higher sensitivity and lower costs, some researchers 
recommend EIE-LVC as a screening test and TR-DPP, 
due to its higher specificity, as a confirmatory test in the 
protocol for CVL diagnosis in Brazil.(34,36) These recom-
mendations are consistent with the results from the pres-
ent study in which the sensitivity was higher when tests 
were analysed in that sequence.
In the context of the imperfection and heterogeneity 
of the tests used as a reference standard in the validation 
studies, an alternative would be the use of latent-class 
analysis to estimate indirectly the accuracy of tests, as 
Solcà et al.(40) did. In that study, the results for sensitivity 
for TR-DPP and EIE-LVC were 47.1% and 43.8%, respec-
tively. Their data are substantially different from the ac-
curacy studies that used other approaches for validation.(40)
The difficulty in establishing a reference standard 
also resides in the lack of consensus on how to determine 
whether a dog is infected. Traditionally, serological tests 
were used as a reference to define the state of infection; 
however, there was the acknowledged lack of sensitivity. 
More recently, molecular techniques have allowed the 
detection of infection in animals that are seronegative.
(14,17) This more sensitive form of detecting asymptomatic 
infection can contribute to better understanding of the 
dynamics of transmission and the lack of efficacy in the 
measures for CVL control that are currently based on the 
application of serological tests. That is a relevant point 
because these dogs, although asymptomatic, may act as 
competent reservoirs.(15,16,17,18,19,20,41)
Similarly, the diagnosis of asymptomatic infection 
in humans is also challenging because the time between 
infection development and production of antibodies at 
detectable levels is not clear, providing room for mo-
lecular techniques for enhancing the early detection of 
infection.(42,43) 
In a context in which the absence of a well-defined 
reference standard interferes with study results, this is 
the first study to use a composite reference standard that 
includes both conventional parasitological techniques 
and a combination of molecular tests in blood and bone 
marrow samples that can be obtained with relative ease.
With this composite reference standard, the accuracy 
results for the DAT-Canis test were similar to the those 
of other evaluated tests that have been used for routine 
CVL diagnosis in the visceral leishmaniasis control pro-
gram in Brazil. Despite this similarity, the results for 
the accuracy values were inferior to those observed in 
previous studies.(5,8,21,44) The main difference between 
the present study and previous studies is at least partly 
caused by the type of reference standard used in each 
study. In this study, the introduction of very sensitive 
molecular tests applied to blood and bone marrow sam-
ples certainly contributed to the identification of 56.09% 
of the samples as positive. If the reference standard had 
simply involved the direct parasitological examination 
and culture of bone marrow, 17.07% of the samples 
would have been identified as positive. In that scenario, 
the sensitivity of DAT-Canis would have been estimat-
ed as 28.57% (CI95% 13.81 to 49.96) and its specificity 
as 91.18% (CI95% 84.08 to 95.29). A similar pattern is 
observed in the accuracy of other serological tests that 
were challenged against the reference standard used in 
this study. The problem of low sensitivity in the evalu-
ated techniques is rather concerning because the refer-
ence standard used would still be open to enhancement 
with the inclusion of molecular diagnostics using skin 
tissue, which would probably hinder the performance of 
the evaluated serological tests even more.(45)
In the present study, it was not possible to establish 
the influence of symptomatology on test accuracy be-
cause most dogs were asymptomatic and because there 
was no significant difference in symptom score between 
the infected and non-infected groups. That difference 
in the detection capability for CVL in symptomatic and 
asymptomatic dogs was explored in other studies with 
different serological techniques. Paltrinieri et al.(46) men-
tioned that the development of sensitivity for indirect 
immunofluorescence in detecting CVL is, on average, 
90% for symptomatic animals and 29.4% in asymptom-
atic animals. In the work by Santarém et al.(47) when us-
ing ELISA rK 39, the sensitivity was 88% in symptom-
atic animals and 56% in asymptomatic ones. In other 
research, the Ministry of Health’s protocol accuracy 
achieved a sensitivity of 95.24 (CI95% 77.33 to 99.15) 
and specificity of 61.11 (CI95% 38.62 to 79.69) in symp-
tomatic dogs. In asymptomatic dogs, the sensitivity was 
51.35 (CI95% 35.89 to 66.55), and the specificity was 
93.75 (CI95% 85 to 97.54).(10)
These results reinforce the concerns with using sero-
logical tests to identify asymptomatic dogs, considering 
that serological diagnosis is the primary surveying tool 
for controlling CVL. Thus, it is possible that dogs that 
were screened and considered seronegative by serologi-
cal protocols may have been infected, and they may have 
remained as a reservoir for a longer time without any in-
tervention. As stated by Lopes et al.,(7) one in every five 
seronegative dogs may have been infected, highlighting 
the concern that has been expressed by several authors 
regarding the real detection capacity of the tests current-
ly in use by control programs.(3,7,34,36)
The need for new diagnostic methods for surveys 
on dog populations that can discern both asymptomatic 
and symptomatic animals in an accurate way persists 
because that is a key element to defining the success or 
failure of CVL control.
The paradigms traditionally applied to diagnostic 
test validation for CVL are currently being challenged by 
molecular techniques and new knowledge on the role of 
these tests, and by their possible meanings in the context 
of the natural evolution of the infection or its prognosis 
after specific therapeutic interventions. Molecular tests 
are necessary to achieve a consensus on the reference 
standard for diagnosing the several stages of the canine 
disease. Attention is to be given to the results of molecu-
lar tests as infection markers for arthropod vectors in 
dogs because there are no easily verifiable markers for 
measuring that phenomenon. The molecular revolution 
has also affected the paradigms for diagnosing HVL. 
With more sensitive protocols, it is possible to diagnose 
patients in different stages of infection and in different 
types of clinical samples, including immunosuppressed 
patients who do not present detectable levels of antibod-
ies in traditional serological tests.(48,49)
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The actual implication of our results for controlling 
visceral leishmaniasis and the application of extreme 
control measures such as dog culling should be further 
researched. It seems clear that in the near future such 
extreme measures will be abandoned because of its low 
acceptance by the affected communities and the ethical 
issues linked to appropriate animal care. In addition, 
newer control measures have been under evaluation such 
as insecticide-impregnated dog collars and preventive or 
therapeutic vaccines. For those interventions maintain-
ing infected dogs in the community, careful monitoring 
of infection rates will be crucial for effectiveness evalu-
ation, and our data showed that current serological tests 
will fail to detect most of the infected animals without 
clinical signs of visceral leishmaniasis. Finally, the in-
fectiousness of asymptomatic dogs with positive results 
that were revealed exclusively through parasite DNA de-
tection assays deserves special attention until proven to 
the contrary, it seems reasonable to consider those dogs 
as potential sources of infection.
Although the endemic area where the study was done 
had produced a small number of HVL cases, human in-
fection seems to be of relevant magnitude.(50) The area 
has been monitored and targeted with the traditional in-
terventions recommended by the visceral leishmaniasis 
control program. Moreover, it would be useful to con-
sider that the rapid dispersion of CVL across the conti-
nent brings the need of sensitive tests for early detection 
of such dispersion. Currently available serological tests 
could be inadequate for that purpose and improving sen-
sitivity will be crucial for that setting.
With the results from the present study, we conclude 
that the low sensitivity in serological tests for diagnosing 
asymptomatic dogs must be considered one of the top 
concerns for controlling visceral leishmaniasis in Brazil. 
It seems advisable to suggest that the concern about the 
lack of test specificity for diagnosing CVL may not be as 
relevant as the low sensitivity, because the results herein 
suggest that the problems in specificity from other stud-
ies may have been determined by classification errors 
caused by imperfect reference standards that presented 
low sensitivity themselves.
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